30 March 2016 Future access to cancer medicines in the UK By New Statesman Download the PDF Content from our partners Unlocking investment in UK life sciences through manufacturing Ioana Parsons Data defines a new era for fundraising Spotlight A prescription for success: improving the UK’s access to new medicines Rippon Ubhi Related International Germany’s hard-right architecture The Staggers The pleasures and sorrows of solo travelling The Weekend Essay What is Starmer’s story?